Safety and efficacy of image-guided enzyme-targeting radiosensitization and intraoperative radiotherapy for locally advanced unresectable pancreatic cancer

Oncology Letters

Volumn 8, Issue 1, 2014, Pages 404-408

  Nishioka, Akihito ^a   Ogawa, Yasuhiro ^a   Miyatake, Kana ^a   Tadokoro, Michiko ^a   Nogami, Munenobu ^a   Hamada, Norihiko ^a   Kubota, Kei ^a   Kariya, Shinnji ^a   Kohsaki, Takuhiro ^a   Saibara, Toshiji ^a   Okabayashi, Takehiro ^a   Hanazaki, Kazuhiro ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Enzyme targeting radiosensitization; Hydrogen peroxide; Image guided radiotherapy; Intraoperative radiotherapy; Pancreatic cancer; Radiosensitizer

Indexed keywords

CONTRAST MEDIUM; GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; HYALURONIC ACID; HYDROGEN PEROXIDE; OXYDOL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CONTROL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DOPPLER FLOWMETER; FEMALE; FOLLOW UP; HUMAN; IMAGE GUIDED ENZYME TARGETING RADIOSENSITIZATION; INTRAOPERATIVE RADIOTHERAPY; MALE; MIDDLE AGED; MILD HEPATIC IMPAIRMENT; MULTIPLE CYCLE TREATMENT; PANCREAS CANCER; PATIENT SAFETY; RADIOSENSITIZATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84901234610     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2101     Document Type: Article

References (27)

1. Ogawa Y, Takahashi T, Kobayashi T, et al: Mechanism of apoptotic resistance of human osteosarcoma cell line, HS-Os-1, against irradiation. Int J Mol Med 12: 453-458, 2003.
2. Ogawa Y, Takahashi T, Kobayashi T, et al: Apoptotic-resistance of the human osteosarcoma cell line HS-Os-1 to irradiation is converted to apoptotic-susceptibility by hydrogen peroxide: a potent role of hydrogen peroxide as a new radiosensitizer. Int J Mol Med 12: 845-850, 2003.
3. Ogawa Y, Takahashi T, Kobayashi T, et al: Immunocytochemical characteristics of human osteosarcoma cell line HS-Os-1: possible implication in apoptotic resistance against irradiation. Int J Mol Med 14: 397-403, 2004.
4. Kariya S, Sawada K, Kobayashi T, et al: Combination treatment of hydrogen peroxide and X-rays induces apoptosis in human prostate cancer PC-3 cells. Int J Radiat Oncol Biol Phys 75: 449-454, 2009.
5. Ogawa Y, Ue H, Tsuzuki K, et al: New radiosensitization treatment (KORTUC I) using hydrogen peroxide solution-soaked gauze bolus for unresectable and superficially exposed neoplasms. Oncol Rep 19: 1389-1394, 2008.
6. Ogawa Y, Kubota K, Ue H, et al: Phase I study of a new radiosensitizer containing hydrogen peroxide and sodium hyaluronate for topical tumor injection: a new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II). Int J Oncol 34: 609-618, 2009.
7. Miyatake K, Kubota K, Ogawa Y, et al: Non-surgical care for locally advanced breast cancer: radiologically assessed therapeutic outcome of a new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II) with systemic chemotherapy. Oncol Rep 24: 1161-1168, 2010.
8. Ogawa Y, Kubota K, Ue H, et al: Safety and effectiveness of a new enzyme-targeting radiosensitization treatment (KORTUC II) for intratumoral injection for low-LET radioresistant tumors. Int J Oncol 39: 553-560, 2011.
9. Parkin DM, Bray F, Ferlay J, et al: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
10. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
11. Philip PA, Mooney M, Jaffe D, et al: Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment. J Clin Oncol 27: 5660-5669, 2009.
12. Burris HA III, Moore MJ, Andersen J, et al: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15: 2403-2413, 1997.
13. Yamaguchi K, Nakamura K, Kobayashi K, et al: ERT following IORT improves survival of patients with respectable pancreatic cancer. Hepatogastroenterology 52: 1244-1249, 2005.
14. Ruano-Ravina A, Almazán Ortega R, and Guedea F: Intraoperative radiotherapy in pancreatic cancer: a systematic review. Radiother Oncol 87: 318-325, 2008.
15. Shirasaka T, Shimamato Y, Ohshimo H, et al: Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs 7: 548-557, 1996.
16. Therasse P, Arbuck SG, Eisenhauer EA, et al: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216, 2000.
17. Jette DC, Wiebe LI and Chapman JD: Synthesis and in vivo studies of the radiosensitizer 4-[82Br]bromomisonidazole. Int J Nucl Med Biol 10: 205-210, 1983.
18. Coleman CN: Hypoxic cell radiosensitizers: expectations and progress in drug development. Int J Radiat Oncol Biol Phys 11: 323-329, 1985.
19. Hall EJ: Oxygen effect and reoxygenation. In: Radiobiology for the Radiologist. Hall EJ (ed). 5th edition. J.B. Lippincott Co., Philadelphia, PA, pp91-111, 2000.
20. Lawrence TS, Blackstock AW and McGinn C: The mechanism of action of radiosensitization of conventional chemotherapeutic agents. Semin Radiat Oncol 13: 13-21, 2003.
21. Choy H and Milas L: Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance? J Natl Cancer Inst 95: 1440-1452, 2003.
22. Overgaad J: Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors. Oncol Res 6: 509-518, 1994.
23. O'Connor JK, Sause WT, Hazard LJ, et al: Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampllary adenocarcinoma. Int J Radiat Oncol Biol Phys 63: 1060-1066, 2005.
24. Ma HB, Di ZL, Wang XJ, et al: Effect of intraoperative radiotherapy combined with external beam radiotherapy following internal drainage for advanced pancreatic cancer. World J Gastroenterol 10: 1669-1771, 2004.
25. Furuse J, Kinoshita T, Kawashima M, et al: Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma. Cancer 97: 1346-1352, 2003.
26. Ogawa K, Karasawa K, Ito Y, et al; JROSG Working Subgroup of Gastrointestinal Cancers: Intraoperative radiotherapy for unresectable pancreatic cancer: a multi-institutional retrospective analysis of 144 patients. Int J Radiat Oncol Biol Phys 80: 111-118, 2011.
27. Sunamura M, Karasawa K, Okamoto A, et al; PR-350 study group: Phase III trial of radiosensitizer PR-350 combined with intraoperative radiotherapy for the treatment of locally advanced pancreatic cancer. Pancreas 28: 330-334, 2004.